Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Upgrades Unity Biotechnology to Buy

Citigroup analyst Yigal Nochomovitz upgrades Unity Biotechnology (NASDAQ:UBX) from Sell to Buy.

byBenzinga Newsdesk

June 28, 2021

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Unity Biotechnology (NASDAQ:UBX) from Sell to Buy.

SMART Global Shares Plummet After Q3 Results, Guides Q4 Below Consensus

By Akanksha Bakshi

June 29, 4:46 PM

SMART Global Holdings Inc. (NASDAQ:SGH) reported third-quarter sales growth of 5.7% year-over-year to $463 million, beating the consensus of $455.17…

SGH

Accolade Q1 EPS $(0.84) Misses $(0.37) Estimate, Sales $59.50M Beat $55.66M Estimate

By Benzinga Newsdesk

July 8, 4:06 PM

Accolade (NASDAQ:ACCD) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.37) by 127.03 percent. This is a 54.84 percent increase over losses of $(1.86) per share from the

ACCD

Needham Maintains Buy on Clean Energy Fuels, Lowers Price Target to $11

By Benzinga Newsdesk

August 6, 7:01 AM

Needham analyst Vikram Bagri maintains Clean Energy Fuels (NASDAQ:CLNE) with a Buy and lowers the price target from $12 to $11.

CLNE

Ascendant Resources Files Technical Report For ITs Lagoa Salgada Project In Portugal

By Benzinga Newsdesk

October 25, 5:42 PM

Ascendant Resources (TSX:ASND) ("Ascendant" or the "Company”) announces the filing on SEDAR (www.sedar.com) of the new NI 43-101 Preliminary Economic Assessment (“PEA”) entitled “NI

TSX:ASND

Citigroup Upgrades Unity Biotechnology to Buy

Related Posts

SMART Global Shares Plummet After Q3 Results, Guides Q4 Below Consensus

Accolade Q1 EPS $(0.84) Misses $(0.37) Estimate, Sales $59.50M Beat $55.66M Estimate

Needham Maintains Buy on Clean Energy Fuels, Lowers Price Target to $11

Ascendant Resources Files Technical Report For ITs Lagoa Salgada Project In Portugal